Securities code: A-share 600613 stock abbreviation: A-share Shanghai Shenqi Pharmaceutical Investment Management Co.Ltd(600613) No.: 2022-003
B shares 900904 B shares magic B shares
Shanghai Shenqi Pharmaceutical Investment Management Co.Ltd(600613)
Announcement on share pledge of controlling shareholders
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
The controlling shareholder of Shanghai Shenqi Pharmaceutical Investment Management Co.Ltd(600613) (hereinafter referred to as "the company" or "the company") Guizhou magic Investment Co., Ltd. (hereinafter referred to as "magic investment") holds 131301620 shares of the company, accounting for 24.59% of the total share capital of the company; 6000000 shares were pledged this time, and 6000000 shares were pledged in total, accounting for 1.12% of the total shares of the company and 4.57% of the shares of the company held by it.
Magic investment and its holding company Guizhou MAGGIS Investment Management Co., Ltd. (hereinafter referred to as "MAGGIS") hold 219303566 shares of the company, accounting for 41.06% of the total share capital of the company; The accumulated pledged shares are 6000000, accounting for 1.12% of the total shares of the company and 2.74% of the total shares of the company.
Recently, the company received the notice of magic investment on share pledge. On February 7, 2022, magic investment pledged 6000000 shares of the company's non tradable shares held by it to Haier Financial Leasing Co., Ltd. (hereinafter referred to as "Haier leasing"), accounting for 1.12% of the company's total shares and 4.57% of the company's shares. The details are as follows:
(I) pledge of shares of listed companies
1. Basic information of this share pledge
yes
This time
no
Whether the pledge accounts for its share of the public pledge is yes no
The shareholder's pledge is limited to shares, the initial pledge is due, and the total financing control of the company held by the pledge right is supplemented
Name: share capital pledge of the person on the date of sale
(10000 shares)
Shares)
east
Magic Haier production 600 no 2022.2.7 2024.2.6 4.57% 1.12%
Investment lease operation
Total 600 4.57% 1.12%
2. The Pledged Shares are not used as guarantee or other guarantee for major asset restructuring, performance compensation and other matters.
3. Cumulative Pledged Shares of controlling shareholders and their holding companies
As of the disclosure date of the announcement, the cumulative Pledged Shares of magic investment and MAGGIS are as follows:
Pledged shares and non Pledged Shares
Pledged and pledged pledged but not pledged shares are accumulated before and after, accounting for the number of shares held by the shareholders of public Pledged Shares, pledged shares, pledged shares, pledged shares, total shares held by the company, medium shares, medium shares, medium name (10000 shares) Proportional charge number charge number share capital restricted sale frozen restricted sale frozen weighing proportion share (ten thousand (ten thousand) shares) (ten thousand (ten thousand) (ten thousand) (10000 shares)
magical
13130.16 24.59% - 600 4.57% 1.12% - Investment
Ji 8800.20 16.48% ----- Sihe
21930.36 41.06% - 600 4.57% 1.12% ----
Note: the data tail difference in the above table is caused by rounding.
2、 Other instructions
This share pledge will not lead to the change of the control right or controlling shareholder of the listed company, and will not have an adverse impact on the production and operation, ownership structure, corporate governance and performance compensation obligations of the listed company. In case of major changes in the above equity pledge, the company will disclose it in time in accordance with relevant regulations.
It is hereby announced.
Shanghai Shenqi Pharmaceutical Investment Management Co.Ltd(600613) board of directors
February 10, 2022
